Quest Diagnostics Incorporated
DGX
$195.23
-$3.38-1.70%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.89% | 15.22% | 13.10% | 6.03% | 1.99% |
| Total Depreciation and Amortization | 15.62% | 19.91% | 19.87% | 15.40% | 12.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.23% | 126.17% | 89.26% | 58.12% | 37.90% |
| Change in Net Operating Assets | 124.88% | 131.67% | 73.49% | -32.91% | -38.62% |
| Cash from Operations | 41.38% | 34.93% | 34.46% | 12.16% | 4.87% |
| Capital Expenditure | -24.00% | -31.55% | -21.72% | -13.77% | -4.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 95.33% | 75.63% | -673.20% | -180.06% | -254.17% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.32% | -220.00% | 218.18% | 211.11% | 197.62% |
| Cash from Investing | 75.24% | 56.39% | -274.45% | -119.53% | -140.15% |
| Total Debt Issued | -77.79% | -85.01% | 55.43% | -15.95% | -28.78% |
| Total Debt Repaid | -233.99% | -40.56% | 23.84% | 47.01% | 83.57% |
| Issuance of Common Stock | 8.22% | 28.13% | 64.15% | 52.54% | 1.39% |
| Repurchase of Common Stock | -182.86% | -15.38% | 34.90% | 34.90% | 42.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.65% | -6.12% | -5.88% | -5.33% | -5.41% |
| Other Financing Activities | 34.62% | 14.49% | -65.52% | 60.75% | 39.53% |
| Cash from Financing | -228.04% | -191.84% | 259.06% | 714.46% | 577.50% |
| Foreign Exchange rate Adjustments | 157.14% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.84% | -153.46% | -66.90% | -195.65% | -136.93% |